Dr. Ashish Kumar is a Professor and Senior Consultant of Gastroenterology and Hepatology at the Institute of Liver, Gastroenterology & Pancreatico-Biliary Sciences, Sir Ganga Ram Hospital, New Delhi. He completed his Gastroenterology training (DM) at the Sanjay Gandhi Postgraduate Institute of Medical Sciences (SGPGIMS), Lucknow, in 2004, and subsequently trained for five years under the renowned Dr. Shiv Kumar Sarin at G. B. Pant Hospital and the Institute of Liver & Biliary Sciences (ILBS), New Delhi.
He is a recipient of prestigious national and international fellowships, including those of the National Academy of Medical Sciences (FNAMS), the Royal College of Physicians of London and Edinburgh (FRCP), and the American College of Physicians (FACP), and has held visiting fellowships at the National Cancer Center, Tokyo, and the University of California, San Francisco. Dr. Kumar serves as Associate Editor of the Journal of Clinical and Experimental Hepatology and has authored more than 250 scientific papers in leading journals such as Gastroenterology, Annals of Internal Medicine, and Gut.
With an h-index of 57, he has been named among the top 2% of scientists worldwide by Elsevier and Stanford University every year from 2021 to 2025. He is the lead author of the Indian Guidelines on the Treatment of Hepatocellular Carcinoma under the aegis of INASL. His clinical and research interests span fatty liver disease, cirrhosis, liver cancer, diabetes-related liver disease, portal hypertension, and liver failure — areas in which he continues to earn national and international recognition.
1. Arora A, Kumar A, Anand AC, Kumar A, Yadav A, Bhagwat A, Mullasari AS, Satwik A, Saraya A, Mehta A, Roy D, Reddy DN, Makharia G, Murthy JMK, Roy J, Sawhney JPS, Prasad K, Goenka M, Philip M, Umaiorubahan M, Sinha N, Mohanan PP, Sylaja PN, Ramakrishna P, Kerkar P, Rai P, Kochhar R, Yadav R, Nijhawan S, Sinha SK, Hastak SM, Viswanathan S, Ghoshal UC, Madathipat U, Thakore V, Dhir V, Saraswat VA, Nabi Z. Position statement from the Indian Society of Gastroenterology, Cardiological Society of India, Indian Academy of Neurology and Vascular Society of India on gastrointestinal bleeding and endoscopic procedures in patients on antiplatelet and/or anticoagulant therapy. Indian J Gastroenterol. 2023 Jun 5. doi: 10.1007/s12664-022-01324-6. Epub ahead of print. PMID: 37273146. (PubMed)
2. Maiwall R, Pasupuleti SSR, Choudhury A, Kim DJ, Sood A, Goyal O, Midha V, Devarbhavi H, Arora A, Kumar A, Sahu MK, Maharshi S, Duseja AK, Singh V, Taneja S, Rao PN, Kulkarni A, Ghazinian H, Hamid S, Eapen CE, Goel A, Shreshtha A, Shah S, Hu J, Prasad VGM, Yuemin N, Shaojie X, Dhiman RK, Chen T, Ning Q, Panackel C, Niriella MA, Lama TK, Tan SS, Dokmeci AK, Shukla A, Sharma MK, Sarin SK. AARC score determines outcomes in patients with alcohol-associated hepatitis: a multinational study. Hepatol Int. 2022 Dec 26. doi: 10.1007/s12072-022-10463-z. Epub ahead of print. PMID: 36571711.
3. Srivastava S, Kumar A, Maheshwari A, Kapse G. Proposed survey questionnaire for the diagnosis of irritable bowel syndrome: Based on patient complaints. Int J Adv Res Ideas Innov Technol. 2023;9(2):44-47.
4. Duseja A, Singh SP, De A, Madan K, Rao PN, Shukla A, Choudhuri G, Saigal S, Shalimar, Arora A, Anand AC, Das A, Kumar A, Eapen CE, Devadas K, Shenoy KT, Panigrahi M, Wadhawan M, Rathi M, Kumar M, Choudhary NS, Saraf N, Nath P, Kar S, Alam S, Shah S, Nijhawan S, Acharya SK, Aggarwal V, Saraswat VA, Chawla YK. Indian National Association for Study of the Liver (INASL) Guidance Paper on Nomenclature, Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease (NAFLD). J Clin Exp Hepatol. 2023 Mar-Apr;13(2):273-302. doi: 10.1016/j.jceh.2022.11.014. Epub 2022 Dec 7. PMID: 36950481; PMCID: PMC10025685.
5. Anikhindi S, Anikhindi A, Kumar A, Arora A. A Review on "IL-1 Receptor Antagonist Plus Pentoxifylline and Zinc for Severe Alcohol-Associated Hepatitis". J Clin Exp Hepatol. 2023 May-Jun;13(3):533-535. doi: 10.1016/j.jceh.2023.01.011. Epub 2023 May 18. PMID: 37250885; PMCID: PMC10213870.
6. Kumar A. Making Sense of the Antisense Therapy for Hepatitis B - Bepirovirsen. J Clin Exp Hepatol. 2023 May-Jun;13(3):535-537. doi: 10.1016/j.jceh.2022.12.013. Epub 2023 May 18. PMID: 37250875; PMCID: PMC10213862.
7. Kumar A. Will Tirzepatide Become a Game-Changer Anti-Obesity Drug? J Clin Exp Hepatol. 2023 May-Jun;13(3):532-533. doi: 10.1016/j.jceh.2023.01.012. Epub 2023 May 18. PMID: 37250871; PMCID: PMC10213833.
8. Kumar A. Hepatic Dysfunction in Kidney Transplant Recipients. In: Bhargava V, Sahay M, Meena P, Sakhuja V, Gupta A, eds. Textbook of Kidney Transplantation. First edition. Jaypee Brothers Medical Publishers; 2023:269-274.
9. Kumar A, Maruyama H, Arora A, Sharma P, Anikhindi SA, Bansal N, Kumar M, Ranjan P, Sachdeva M, Khare S. Diagnostic accuracy of transient elastography in diagnosing clinically significant portal hypertension in patients with chronic liver disease: a systematic review and meta-analysis. J Med Ultrason (2001). 2022 Jul;49(3):333-346. doi: 10.1007/s10396-022-01239-x. Epub 2022 Jul 25. PMID: 35876975.
10. Arora A, Singal A, Sharma P, Kumar A. A proposed five-step simplified algorithm for the management of hepatocellular carcinoma in India. Curr Med Res Pract. 2022, 12:224. 10.4103/cmrp.cmrp_69_22.
11. Padole P, Arora A, Sharma P, Chand P, Verma N, Kumar A. Saroglitazar for Nonalcoholic Fatty Liver Disease: A Single Centre Experience in 91 Patients. J Clin Exp Hepatol. 2022 Mar-Apr;12(2):435-439. doi: 10.1016/j.jceh.2021.06.015. Epub 2021 Jun 19. PMID: 35535066; PMCID: PMC9077151.
12. Singla V, Arora A, Rana SS, Kohle M, Khare S, Kumar A, Bansal N, Sharma P. EUS-Guided Rendezvous and Tractogastrostomy: A Novel Technique for Disconnected Pancreatic Duct Syndrome with External Pancreatic Fistula. J Dig Endosc 2022; 13(03): 129-135. DOI: 10.1055/s-0042-1754334.
13. Kumar A, Sharma P, Arora A. Letter to the editor: In patients with established NASH cirrhosis, is there no role of weight reduction in reversing fibrosis? Hepatology. 2022 Jul;76(1):E3-E4. doi: 10.1002/hep.32375. Epub 2022 Feb 15. PMID: 35092319.
14. Kumar A. Alcohol-related Liver Disease. In: Kamath SA, ed. API Textbook of Medicine. Vol 2. 12th ed. Jaypee Brothers Medical Publishers; 2022:1599-1607.
